Enhancing protective efficacy and immunogenicity of hemagglutinin-based influenza vaccine utilizing adjuvants developed by BECC
Sayan Das, Brandon M Tenaglia, Devon Riley, Sydney Speed, Lauren Baracco, Francesca M. Gardner, David J. Varisco, Hyojik Yang, Haye Nijhuis, Lucas J. Kerstetter, Florian Krammer, Weina Sun, Lynda Coughlan, Matthew B. Frieman, Robert K. Ernst
This study evaluates BECC adjuvants' ability to enhance HA-based influenza vaccine efficacy in mice, showing improved immune responses and viral clearance.
bioRxiv · Jun 3, 2025 · PreprintImmunology